Pei, Z.; Song, Q.; Xu, J.; Yu, S.; Ma, H.
The Cyclic Antimicrobial Peptide C-LR18 Has Enhanced Antibacterial Activity, Improved Stability, and a Longer Half-Life Compared to the Original Peptide. Antibiotics 2025, 14, 312.
https://doi.org/10.3390/antibiotics14030312
AMA Style
Pei Z, Song Q, Xu J, Yu S, Ma H.
The Cyclic Antimicrobial Peptide C-LR18 Has Enhanced Antibacterial Activity, Improved Stability, and a Longer Half-Life Compared to the Original Peptide. Antibiotics. 2025; 14(3):312.
https://doi.org/10.3390/antibiotics14030312
Chicago/Turabian Style
Pei, Zhihua, Qiaoxi Song, Jingqi Xu, Shuang Yu, and Hongxia Ma.
2025. "The Cyclic Antimicrobial Peptide C-LR18 Has Enhanced Antibacterial Activity, Improved Stability, and a Longer Half-Life Compared to the Original Peptide" Antibiotics 14, no. 3: 312.
https://doi.org/10.3390/antibiotics14030312
APA Style
Pei, Z., Song, Q., Xu, J., Yu, S., & Ma, H.
(2025). The Cyclic Antimicrobial Peptide C-LR18 Has Enhanced Antibacterial Activity, Improved Stability, and a Longer Half-Life Compared to the Original Peptide. Antibiotics, 14(3), 312.
https://doi.org/10.3390/antibiotics14030312